PL2323647T3 - Długotrwałe leczenie objawowej niewydolności serca - Google Patents

Długotrwałe leczenie objawowej niewydolności serca

Info

Publication number
PL2323647T3
PL2323647T3 PL09777388T PL09777388T PL2323647T3 PL 2323647 T3 PL2323647 T3 PL 2323647T3 PL 09777388 T PL09777388 T PL 09777388T PL 09777388 T PL09777388 T PL 09777388T PL 2323647 T3 PL2323647 T3 PL 2323647T3
Authority
PL
Poland
Prior art keywords
long
heart failure
term treatment
symptomatic heart
symptomatic
Prior art date
Application number
PL09777388T
Other languages
English (en)
Inventor
Claudio Cavazza
Maria Giovanna Caccia
Original Assignee
Spa Soc Prodotti Antibiotici S P A
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Spa Soc Prodotti Antibiotici S P A, Sigma Tau Ind Farmaceuti filed Critical Spa Soc Prodotti Antibiotici S P A
Publication of PL2323647T3 publication Critical patent/PL2323647T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Meat, Egg Or Seafood Products (AREA)
  • Magnetic Heads (AREA)
PL09777388T 2008-08-07 2009-07-23 Długotrwałe leczenie objawowej niewydolności serca PL2323647T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP08161994 2008-08-07
EP09777388.1A EP2323647B1 (en) 2008-08-07 2009-07-23 Long-term treatment of symptomatic heart failure
PCT/EP2009/005347 WO2010015335A1 (en) 2008-08-07 2009-07-23 Long-term treatment of symptomatic heart failure

Publications (1)

Publication Number Publication Date
PL2323647T3 true PL2323647T3 (pl) 2015-03-31

Family

ID=40101155

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09777388T PL2323647T3 (pl) 2008-08-07 2009-07-23 Długotrwałe leczenie objawowej niewydolności serca

Country Status (20)

Country Link
US (1) US8592439B2 (pl)
EP (1) EP2323647B1 (pl)
JP (1) JP5563573B2 (pl)
KR (1) KR20110058775A (pl)
CN (1) CN102149376B (pl)
AU (1) AU2009278317B2 (pl)
BR (1) BRPI0917403A2 (pl)
CA (1) CA2732071C (pl)
CY (1) CY1115785T1 (pl)
DK (1) DK2323647T3 (pl)
EA (1) EA020237B1 (pl)
ES (1) ES2524596T3 (pl)
HR (1) HRP20141149T1 (pl)
MX (1) MX2011001419A (pl)
PL (1) PL2323647T3 (pl)
PT (1) PT2323647E (pl)
RS (1) RS53694B1 (pl)
SI (1) SI2323647T1 (pl)
SM (1) SMT201500019B (pl)
WO (1) WO2010015335A1 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2826663A1 (en) 2011-02-07 2012-08-16 Mochida Pharmaceutical Co., Ltd. Therapeutic agent for diastolic congestive heart failure
US20140350957A1 (en) * 2011-12-27 2014-11-27 Koninklijke Philips N.V. Method and system for reducing early readmission
TWI725937B (zh) * 2014-06-06 2021-05-01 美商海洋原料公司 ω-３組成物、劑型及使用方法
WO2019022436A2 (ko) * 2017-07-27 2019-01-31 에리슨제약(주) Nep 저해제 및 베타-차단제를 포함하는 약제학적 조성물

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2218984B (en) 1988-05-27 1992-09-23 Renafield Limited Process for preparing high-concentration mixtures of polyunsaturated fatty acids & their esters and their prophylactic or therapeutic uses
GB8819110D0 (en) 1988-08-11 1988-09-14 Norsk Hydro As Antihypertensive drug & method for production
CN1082909A (zh) 1993-01-03 1994-03-02 潘玉珍 精制二十二碳六烯酸乙酯复合溶栓、抗痴呆药剂
US5760081A (en) 1994-05-10 1998-06-02 The General Hospital Corporation Omega 3 fatty acids in the prevention of ventricular fibrillation
US5541225A (en) * 1994-10-11 1996-07-30 The General Hospital Corporation α-Linolenic acid and eicosatetraynoic acid in the prevention and treatment of ventricular tachyarrhythmia
IT1277953B1 (it) 1995-12-21 1997-11-12 Sigma Tau Ind Farmaceuti Composizione farmaceutica contenente l-carnitina o una alcanoil l- carnitina e un acido poliinsaturo della serie 3-omega utile per
IT1308613B1 (it) 1999-02-17 2002-01-09 Pharmacia & Upjohn Spa Acidi grassi essenziali nella prevenzione di eventi cardiovascolari.
ITMI20010129A1 (it) 2001-01-25 2002-07-25 Pharmacia & Upjohn Spa Acidi grassi essenziali nella terapia di insufficienza cardiaca e scompenso cardiaco
ITMI20012384A1 (it) 2001-11-12 2003-05-12 Quatex Nv Uso di acidi grassi poliinsaturi per la prevenzione primaria di eventi cardiovascolari maggiori
US20060135610A1 (en) * 2004-12-22 2006-06-22 Bortz Jonathan D Cardiovascular compositions
JP2010506841A (ja) * 2006-10-13 2010-03-04 リライアント・ファーマシューティカルズ・インコーポレイテッド 抗不整脈薬およびオメガ−３脂肪酸およびそれらの組合せ品による治療法

Also Published As

Publication number Publication date
JP5563573B2 (ja) 2014-07-30
WO2010015335A1 (en) 2010-02-11
AU2009278317B2 (en) 2014-12-18
EA201100143A1 (ru) 2011-10-31
US20110178111A1 (en) 2011-07-21
JP2011529928A (ja) 2011-12-15
WO2010015335A8 (en) 2010-04-29
US8592439B2 (en) 2013-11-26
PT2323647E (pt) 2014-12-16
HRP20141149T1 (hr) 2015-02-13
CY1115785T1 (el) 2017-01-25
DK2323647T3 (en) 2014-12-08
CA2732071C (en) 2018-02-13
RS53694B1 (sr) 2015-04-30
CN102149376A (zh) 2011-08-10
EP2323647B1 (en) 2014-09-10
AU2009278317A1 (en) 2010-02-11
SMT201500019B (it) 2015-03-05
HK1160790A1 (en) 2012-08-17
AU2009278317A8 (en) 2011-03-31
BRPI0917403A2 (pt) 2015-12-01
CA2732071A1 (en) 2010-02-11
CN102149376B (zh) 2013-12-25
EP2323647A1 (en) 2011-05-25
KR20110058775A (ko) 2011-06-01
MX2011001419A (es) 2011-05-25
ES2524596T3 (es) 2014-12-10
SI2323647T1 (sl) 2015-01-30
EA020237B1 (ru) 2014-09-30

Similar Documents

Publication Publication Date Title
EP2440209A4 (en) COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF HEART FAILURE
DK2808024T3 (da) Bifidobakterier til behandling af kongestiv hjerteinsufficiens
GB2495649B (en) Medical implant
IL215975A (en) Heart failure device
IL259475A (en) Combined therapy for the treatment of diabetes
GB0905444D0 (en) Heart valve prosthesis
GB0906642D0 (en) Cardiac pump
EP2288366A4 (en) METHOD FOR TREATING CHRONIC HEART FAILURE
WO2010132347A9 (en) Docosahexaenoic acid for the treatment of heart failure
ZA201109332B (en) Treatment of heart failure with normal ejection fraction
IL212365A0 (en) Catheter structure
GB2475778B (en) Medical implant
PL2473172T3 (pl) Kompozycje bisfosfonianowe i sposoby do leczenia niewydolności serca
PL2323647T3 (pl) Długotrwałe leczenie objawowej niewydolności serca
GB0806047D0 (en) Treatment of heart failure
BR112012002880A2 (pt) desfibrilador cardíaco
GB0816662D0 (en) Treatment of heart failure
GB0804320D0 (en) Treatment of heart failure
ZA201005770B (en) The treatment of damaged skin
HK1168551A (en) Treatment of heart failure with normal ejection fraction
TWM372181U (en) Structure of artificial vascular
TWM361995U (en) Cylindrical cuff structure of sphygmomanometer
ZA201101773B (en) Compositions and methods for treating heart failure
TWM371505U (en) Improved structure of urn cabinet
HK1169604A (en) Compositions and methods for the prevention and treatment of heart failure